Does the media prefer PACS or AVAH?

In the previous week, PACS Group and PACS Group both had 2 articles in the media. Aveanna Healthcare's average media sentiment score of 0.97 beat PACS Group's score of 0.43 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aveanna Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CAI or AVAH?

In the previous week, Caris Life Sciences had 5 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Caris Life Sciences and 2 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.97 beat Caris Life Sciences' score of 0.73 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SHC or AVAH?

In the previous week, Sotera Health had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 4 mentions for Sotera Health and 2 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.97 beat Sotera Health's score of 0.91 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AVAH or BLLN?

In the previous week, Billiontoone had 7 more articles in the media than Aveanna Healthcare. MarketBeat recorded 9 mentions for Billiontoone and 2 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.97 beat Billiontoone's score of -0.55 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media refer more to AVAH or CELC?

In the previous week, Celcuity had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 4 mentions for Celcuity and 2 mentions for Aveanna Healthcare. Celcuity's average media sentiment score of 1.49 beat Aveanna Healthcare's score of 0.97 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aveanna Healthcare (AVAH) Competitors

$7.09 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$7.05 -0.04 (-0.51%)

As of 06/12/2026 07:58 PM Eastern

Compare

AVAH vs. PACS, CAI, SHC, BLLN, and CELC

Should you buy Aveanna Healthcare stock or one of its competitors? MarketBeat compares Aveanna Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aveanna Healthcare include PACS Group (PACS), Caris Life Sciences (CAI), Sotera Health (SHC), Billiontoone (BLLN), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does Aveanna Healthcare compare to PACS Group?

PACS Group (NYSE:PACS) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

In the previous week, PACS Group and PACS Group both had 2 articles in the media. Aveanna Healthcare's average media sentiment score of 0.97 beat PACS Group's score of 0.43 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aveanna Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group presently has a consensus price target of $48.00, suggesting a potential upside of 31.89%. Aveanna Healthcare has a consensus price target of $10.50, suggesting a potential upside of 48.10%. Given Aveanna Healthcare's higher probable upside, analysts plainly believe Aveanna Healthcare is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Aveanna Healthcare has a net margin of 10.37% compared to PACS Group's net margin of 4.49%. Aveanna Healthcare's return on equity of 124.68% beat PACS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Aveanna Healthcare	10.37%	124.68%	7.07%

Aveanna Healthcare has lower revenue, but higher earnings than PACS Group. Aveanna Healthcare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.09	$191.54M	$1.56	23.33
Aveanna Healthcare	$2.43B	0.63	$225.03M	$1.18	6.01

88.0% of Aveanna Healthcare shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Aveanna Healthcare beats PACS Group on 9 of the 15 factors compared between the two stocks.

How does Aveanna Healthcare compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

Aveanna Healthcare has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.26	-$68.09M	-$7.61	N/A
Aveanna Healthcare	$2.43B	0.63	$225.03M	$1.18	6.01

Caris Life Sciences presently has a consensus target price of $27.56, indicating a potential upside of 53.34%. Aveanna Healthcare has a consensus target price of $10.50, indicating a potential upside of 48.10%. Given Caris Life Sciences' higher probable upside, analysts clearly believe Caris Life Sciences is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Aveanna Healthcare has a net margin of 10.37% compared to Caris Life Sciences' net margin of 3.75%. Aveanna Healthcare's return on equity of 124.68% beat Caris Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Aveanna Healthcare	10.37%	124.68%	7.07%

88.0% of Aveanna Healthcare shares are held by institutional investors. 50.0% of Caris Life Sciences shares are held by company insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Caris Life Sciences had 5 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Caris Life Sciences and 2 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.97 beat Caris Life Sciences' score of 0.73 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Aveanna Healthcare beats Caris Life Sciences on 10 of the 15 factors compared between the two stocks.

How does Aveanna Healthcare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

In the previous week, Sotera Health had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 4 mentions for Sotera Health and 2 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.97 beat Sotera Health's score of 0.91 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health presently has a consensus price target of $20.29, indicating a potential upside of 25.30%. Aveanna Healthcare has a consensus price target of $10.50, indicating a potential upside of 48.10%. Given Aveanna Healthcare's higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Aveanna Healthcare has a net margin of 10.37% compared to Sotera Health's net margin of 9.91%. Aveanna Healthcare's return on equity of 124.68% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Aveanna Healthcare	10.37%	124.68%	7.07%

Aveanna Healthcare has higher revenue and earnings than Sotera Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.97	$77.94M	$0.41	39.49
Aveanna Healthcare	$2.43B	0.63	$225.03M	$1.18	6.01

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Sotera Health has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market.

Summary

Aveanna Healthcare beats Sotera Health on 10 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Billiontoone?

Aveanna Healthcare (NASDAQ:AVAH) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Aveanna Healthcare has a net margin of 10.37% compared to Billiontoone's net margin of 0.00%. Aveanna Healthcare's return on equity of 124.68% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.37%	124.68%	7.07%
Billiontoone	N/A	N/A	N/A

88.0% of Aveanna Healthcare shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Billiontoone had 7 more articles in the media than Aveanna Healthcare. MarketBeat recorded 9 mentions for Billiontoone and 2 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.97 beat Billiontoone's score of -0.55 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Aveanna Healthcare has higher revenue and earnings than Billiontoone. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	0.63	$225.03M	$1.18	6.01
Billiontoone	$305.11M	15.24	$7.45M	$0.55	183.85

Aveanna Healthcare presently has a consensus price target of $10.50, indicating a potential upside of 48.10%. Billiontoone has a consensus price target of $125.29, indicating a potential upside of 23.90%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Aveanna Healthcare is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Aveanna Healthcare beats Billiontoone on 12 of the 15 factors compared between the two stocks.

How does Aveanna Healthcare compare to Celcuity?

Aveanna Healthcare (NASDAQ:AVAH) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

Aveanna Healthcare currently has a consensus price target of $10.50, suggesting a potential upside of 48.10%. Celcuity has a consensus price target of $152.09, suggesting a potential upside of 71.76%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Aveanna Healthcare has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market.

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aveanna Healthcare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	0.63	$225.03M	$1.18	6.01
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Aveanna Healthcare has a net margin of 10.37% compared to Celcuity's net margin of 0.00%. Aveanna Healthcare's return on equity of 124.68% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.37%	124.68%	7.07%
Celcuity	N/A	-244.61%	-50.22%

In the previous week, Celcuity had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 4 mentions for Celcuity and 2 mentions for Aveanna Healthcare. Celcuity's average media sentiment score of 1.49 beat Aveanna Healthcare's score of 0.97 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Aveanna Healthcare beats Celcuity on 10 of the 16 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVAH vs. The Competition

Export

Metric	Aveanna Healthcare	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.54B	$5.70B	$6.53B	$12.05B
Dividend Yield	N/A	1.54%	2.67%	5.66%
P/E Ratio	6.01	35.06	23.99	24.42
Price / Sales	0.63	22.17	511.38	110.47
Price / Cash	10.28	16.60	27.48	37.92
Price / Book	7.62	3.12	10.65	6.82
Net Income	$225.03M	$218.81M	$3.57B	$337.56M
7 Day Performance	6.78%	3.25%	0.58%	1.17%
1 Month Performance	-8.16%	1.31%	1.54%	3.16%
1 Year Performance	44.40%	14.98%	25.40%	30.58%

Aveanna Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVAH Aveanna Healthcare	4.8042 of 5 stars	$7.09 flat	$10.50 +48.1%	+44.4%	$1.54B	$2.43B	6.01	35,500
PACS PACS Group	3.8701 of 5 stars	$35.19 +0.3%	$48.00 +36.4%	+250.9%	$5.57B	$5.29B	22.56	47,455	News Coverage Analyst Upgrade
CAI Caris Life Sciences	4.4166 of 5 stars	$16.96 +5.1%	$27.56 +62.5%	N/A	$4.79B	$812.03M	N/A	1,846	Buyback Announcement
SHC Sotera Health	4.0206 of 5 stars	$16.53 +4.2%	$20.29 +22.7%	+41.6%	$4.71B	$1.16B	40.32	3,000
BLLN Billiontoone	3.5507 of 5 stars	$102.39 +8.4%	$125.29 +22.4%	N/A	$4.71B	$305.11M	186.16	620

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aveanna Healthcare (AVAH) Competitors

AVAH vs. PACS, CAI, SHC, BLLN, and CELC

How does Aveanna Healthcare compare to PACS Group?

Summary

How does Aveanna Healthcare compare to Caris Life Sciences?

Summary

How does Aveanna Healthcare compare to Sotera Health?

Summary

How does Aveanna Healthcare compare to Billiontoone?

Summary

How does Aveanna Healthcare compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aveanna Healthcare (AVAH) Competitors

AVAH vs. PACS, CAI, SHC, BLLN, and CELC

How does Aveanna Healthcare compare to PACS Group?

Does the media prefer PACS or AVAH?

Do analysts recommend PACS or AVAH?

Is PACS or AVAH more profitable?

Which has preferable valuation & earnings, PACS or AVAH?

Do insiders and institutionals hold more shares of PACS or AVAH?

Summary

How does Aveanna Healthcare compare to Caris Life Sciences?

Which has preferable earnings & valuation, CAI or AVAH?

Do analysts prefer CAI or AVAH?

Is CAI or AVAH more profitable?

Do insiders and institutionals believe in CAI or AVAH?

Does the media prefer CAI or AVAH?

Summary

How does Aveanna Healthcare compare to Sotera Health?

Does the media prefer SHC or AVAH?

Do analysts prefer SHC or AVAH?

Is SHC or AVAH more profitable?

Which has preferable valuation & earnings, SHC or AVAH?

Do institutionals & insiders believe in SHC or AVAH?

Which has more volatility & risk, SHC or AVAH?

Summary

How does Aveanna Healthcare compare to Billiontoone?

Is AVAH or BLLN more profitable?

Do institutionals and insiders believe in AVAH or BLLN?

Does the media favor AVAH or BLLN?

Which has preferable valuation & earnings, AVAH or BLLN?

Do analysts recommend AVAH or BLLN?

Summary

How does Aveanna Healthcare compare to Celcuity?

Do analysts prefer AVAH or CELC?

Which has more volatility and risk, AVAH or CELC?

Do insiders and institutionals hold more shares of AVAH or CELC?

Which has preferable valuation and earnings, AVAH or CELC?

Is AVAH or CELC more profitable?

Does the media refer more to AVAH or CELC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools